XML 43 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
SEGMENT INFORMATION
9 Months Ended
Sep. 30, 2013
Segment Reporting [Abstract]  
SEGMENT INFORMATION
SEGMENT INFORMATION
 
Our business consists of one operating and reportable segment for the development, manufacturing and marketing of disposable devices and implants for select surgical procedures.  The development, manufacturing and other supporting functions, such as regulatory affairs and distribution, are common across our Company.  We organize and manage our sales and marketing functions according to geography and the surgical specialty that typically employs our products.  Most of the Company’s products are used in Sports Medicine or ENT procedures.
 
Product sales by product area for the periods shown were as follows (in thousands):
 
 
 
Three months ended
September 30, 2013
 
Three months ended
September 30, 2012
 
 
Americas
 
International
 
Total Product Sales
 
Americas
 
International
 
Total Product Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
Sports Medicine
 
$
37,410

 
$
20,674

 
$
58,084

 
$
36,787

 
$
18,414

 
$
55,201

ENT
 
19,938

 
6,791

 
26,729

 
19,677

 
5,846

 
25,523

Other
 
372

 
1,875

 
2,247

 
322

 
1,556

 
1,878

Total product sales
 
$
57,720

 
$
29,340

 
$
87,060

 
$
56,786

 
$
25,816

 
$
82,602


 
 
Nine months ended
September 30, 2013
 
Nine months ended
September 30, 2012
 
 
Americas
 
International
 
Total Product Sales
 
Americas
 
International
 
Total Product Sales
 
 
 
 
 
 
 
 
 
 
 
 
 
Sports Medicine
 
$
114,218

 
$
62,401

 
$
176,619

 
$
113,868

 
$
58,357

 
$
172,225

ENT
 
60,880

 
18,014

 
78,894

 
62,985

 
16,629

 
79,614

Other
 
1,185

 
5,310

 
6,495

 
1,322

 
5,287

 
6,609

Total product sales
 
$
176,283

 
$
85,725

 
$
262,008

 
$
178,175

 
$
80,273

 
$
258,448



 
Internationally, the Company markets and supports its products primarily through its subsidiaries and various distributors.  Product sales attributed to geographic areas are based on the country or regional area where the Company’s customer is domiciled.  Product sales by geography for the periods shown were as follows (in thousands):

 
 
Three months ended
September 30,
 
Nine months ended
September 30,
 
 
2013
 
2012
 
2013
 
2012
 
 
 
 
 
 
 
 
 
United States
 
$
55,616

 
$
53,936

 
$
170,195

 
$
169,937

Non-United States (1)
 
31,444

 
28,666

 
91,813

 
88,511

Total product sales
 
$
87,060

 
$
82,602

 
$
262,008

 
$
258,448

 ___________________________________________
(1) No additional locations are individually significant.
 
Long-lived assets, net by geography, at the balance sheet dates shown were as follows (in thousands):
 
 
 
September 30,
2013
 
December 31,
2012
 
 
 
 
 
United States
 
$
171,232

 
$
109,950

Non-United States (1)
 
58,437

 
44,434

Total long-lived assets
 
$
229,669

 
$
154,384

 ___________________________________________
(1) No additional locations are individually significant.